Clinical Update on Diagnosis, Treatment and Prevention of Dengue
Dengue is a vector-borne disease that has a significant impact on global public health. The vector mosquito belongs to the genus Aedes. Two species play a key role in human transmission: Ae. aegypti, which has adapted to the urban environment of highly populated areas in tropical and subtropical countries, leading to a dramatic increase in dengue cases over the years, and Ae. albopictus, which poses a potential threat to temperate climate countries due to its ability to adapt to colder climates. The disease is widespread across the world, posing a risk to nearly half of the world's population. Although most cases are asymptomatic, dengue causes a burden on healthcare systems and mainly affects the younger population. The disease is also spreading to temperate climate countries, thus becoming a global threat. Vector control measures and vaccine development have been the main prevention strategies, as there is still no effective treatment for the disease.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Acta medica portuguesa - 37(2024), 2 vom: 01. Feb., Seite 126-135 |
Sprache: |
Portugiesisch |
---|
Weiterer Titel: |
Atualização Clínica sobre Diagnóstico, Tratamento e Prevenção da Dengue |
---|
Beteiligte Personen: |
B A Seixas, Jorge [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dengue/diagnosis |
---|
Anmerkungen: |
Date Completed 05.02.2024 Date Revised 05.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.20344/amp.20569 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367987775 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367987775 | ||
003 | DE-627 | ||
005 | 20240205232149.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240204s2024 xx |||||o 00| ||por c | ||
024 | 7 | |a 10.20344/amp.20569 |2 doi | |
028 | 5 | 2 | |a pubmed24n1281.xml |
035 | |a (DE-627)NLM367987775 | ||
035 | |a (NLM)38309298 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a por | ||
100 | 1 | |a B A Seixas, Jorge |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical Update on Diagnosis, Treatment and Prevention of Dengue |
246 | 3 | 3 | |a Atualização Clínica sobre Diagnóstico, Tratamento e Prevenção da Dengue |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.02.2024 | ||
500 | |a Date Revised 05.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Dengue is a vector-borne disease that has a significant impact on global public health. The vector mosquito belongs to the genus Aedes. Two species play a key role in human transmission: Ae. aegypti, which has adapted to the urban environment of highly populated areas in tropical and subtropical countries, leading to a dramatic increase in dengue cases over the years, and Ae. albopictus, which poses a potential threat to temperate climate countries due to its ability to adapt to colder climates. The disease is widespread across the world, posing a risk to nearly half of the world's population. Although most cases are asymptomatic, dengue causes a burden on healthcare systems and mainly affects the younger population. The disease is also spreading to temperate climate countries, thus becoming a global threat. Vector control measures and vaccine development have been the main prevention strategies, as there is still no effective treatment for the disease | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Dengue Vaccines | |
650 | 4 | |a Dengue Virus | |
650 | 4 | |a Dengue/diagnosis | |
650 | 4 | |a Dengue/prevention and control | |
650 | 4 | |a Dengue/therapy | |
650 | 4 | |a Severe Dengue | |
700 | 1 | |a Giovanni Luz, Kleber |e verfasserin |4 aut | |
700 | 1 | |a Pinto Junior, Vitor |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta medica portuguesa |d 1993 |g 37(2024), 2 vom: 01. Feb., Seite 126-135 |w (DE-627)NLM000463329 |x 1646-0758 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2024 |g number:2 |g day:01 |g month:02 |g pages:126-135 |
856 | 4 | 0 | |u http://dx.doi.org/10.20344/amp.20569 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2024 |e 2 |b 01 |c 02 |h 126-135 |